PanTheryx Stock
Intestinal health research, development, and commercialization products
Sign up today and learn more about PanTheryx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About PanTheryx Stock
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specific dietary needs of children with infectious diarrhea, and support overall intestinal health. The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado.
Investors
Funding History
| March 2011 | $1.0M |
|---|---|
| December 2011 | $1.6M |
| August 2012 | $3.5M |
| April 2015 | $9.3M |
| March 2016 | $53.0M |
| September 2017 | $8.9M |
Management
CEO & President
Mark A. Braman
Vice President, Corporate Development and General Counsel
Scott Hyman
Executive Vice President
George Stagnitti
Press
businesswire - Jun, 27 2023
PanTheryx® Renews Exclusive Three-Year Partnership with VitaDairy® in Pediatric and Adult Immunonutritionzpr - Mar, 2 2021
PanTheryx Inc. Acquires TruBiotics® Brand from Bayer HealthCare LLChubs - Sep, 4 2020
Matter boosts awareness of “nature’s superfood” and revolutionary supplements with PanTheryxbusinesswire - Jul, 1 2020
PanTheryx Appoints Tom Feeley as Chief Financial Officerbusinesswire - Apr, 12 2020
Holger Liepmann and Peter Erickson Join PanTheryx Board of Directorsbusinesswire - Jan, 14 2020
PanTheryx Announces New CEO and Chairmanfinsmes - Jun, 28 2019
PanTheryx Raises $50M in Financingbizjournals - Jun, 28 2019
Boulder life science company snags $50M to keep gut health in checkxconomy - Jun, 27 2019
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiomebusinesswire - Apr, 5 2019
Rajiv Shah and Tom Bumol Join PanTheryx Board of Directors as Biotech Expands Pipeline Candidates with Substantial R&D Investmentnanalyze - Mar, 3 2018
7 Startups Treating Disease Using the Microbiomebusinesswire - Feb, 2 2018
Safety and Efficacy of a Novel Intervention for Acute Childhood DiarrheaHerald Analyst - Dec, 15 2017
Asia-Pacific Colostrum Market 2017- PanTheryx, Colostrum BioTec GmbH, Immuno-Dynamics, Ingredia NutritionalExclusive Herald - Dec, 13 2017
Colostrum Market Competition Analysis by Type, Region Forecast 2021DailyCommerceNews - Dec, 13 2017
Global Bovine Colostrum Market Overview 2017- PanTheryx, Colostrum BioTec GmbH, New Image and Ingredia ...Newsient (blog) - Dec, 1 2017
Future of the United States Colostrum Market – Growth, Latest Trend & Forecast 2022Drug Store News - Jul, 21 2017
PanTheryx launches special dietary food targeting diarrhea reliefbusinesswire - Dec, 17 2016
Colorado BioScience Association Recaps Growth Year for State’s Life Science SectorEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
